Status:
COMPLETED
DHEA Treatment for Sjogren's Syndrome
Lead Sponsor:
National Institute of Dental and Craniofacial Research (NIDCR)
Conditions:
Lacrimal Apparatus Disease
Salivary Gland Disease
Eligibility:
FEMALE
Phase:
PHASE2
Brief Summary
This study will evaluate the effectiveness of the male hormone dehydroepiandrosterone (DHEA) in treating Sjogren's syndrome. This autoimmune disorder, in which the immune system attacks the salivary g...
Detailed Description
Primary Sjogren's syndrome (SS) is an autoimmune disease chiefly affecting the exocrine glands. One of the most troublesome manifestations of SS is severe salivary gland dysfunction. There is no accep...
Eligibility Criteria
Females with a diagnosis of Primary Sjogren's Syndrome.
No history of breast cancer.
Key Trial Info
Start Date :
May 1 1997
Trial Type :
INTERVENTIONAL
End Date :
June 1 2002
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00001598
Start Date
May 1 1997
End Date
June 1 2002
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Dental And Craniofacial Research (NIDCR)
Bethesda, Maryland, United States, 20892